Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Jun 1;32(6):840–847. doi: 10.1158/1055-9965.EPI-22-1208

Table 1:

Select characteristics among cases and controls in the New England Bladder Cancer Study and cases in The Cancer Genome Atlas.

New England Bladder Cancer Study (NEBCS) The Cancer Genome Atlas (TCGA)
Characteristic Cases*
N=307
Controls
N=1,418
Cases*
N=383
Age; N (%)
<55 52 (17.0) 255 (18.0) 45 (11.8)
55–64 87 (28.3) 336 (23.7) 107 (27.9)
65–74 109 (35.5) 544 (38.3) 127 (33.2)
75+ 59 (19.2) 283 (20.0) 104 (27.2)
Sex; N (%)
Female 74 (24.1) 379 (26.7) 94 (24.5)
Male 233 (75.9) 1,039 (73.3) 289 (75.5)
Race; N (%)
White 279 (90.9) 1,313 (92.6) 301 (78.6)
Non-White 28 (9.1) 105 (7.4) 58 (17.8)
Smoking; N (%)
Occasional smokers 4 (1.3) 40 (2.8) N/A
Never smokers 46 (15.0) 472 (33.3) 95 (24.8)
Former smokers 154 (50.2) 699 (49.3) 187 (48.8)
Current smokers 103 (33.5) 206 (14.5) 83 (21.7)
Stage/Grade; N (%)
Ta, Low-Grade 139 (45.3) N/A 0 (0.0)
Ta, High-Grade 60 (19.5) N/A 0 (0.0)
T1, High-Grade 61 (19.9) N/A 0 (0.0)
T2+ (MI) 47 (15.3) N/A 383 (100.0)
Diesel Exposure; N (%)
Unexposed 126 (41.0) 639 (45.1) 184 (48.0)
Possibly exposed 37 (12.1) 165 (11.6) N/A
Exposed 141 (45.9) 605 (42.7) 56 (14.6)
Missing 3 (1.0) 9 (0.6) 143 (37.4)
*

Excludes cases that were dropped after quality control.

N/A=Not Applicable or data not collected/available.